These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 11356937)

  • 1. An oral drug delivery system targeting immune-regulating cells ameliorates mucosal injury in trinitrobenzene sulfonic acid-induced colitis.
    Nakase H; Okazaki K; Tabata Y; Uose S; Ohana M; Uchida K; Nishi T; Debreceni A; Itoh T; Kawanami C; Iwano M; Ikada Y; Chiba T
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1122-8. PubMed ID: 11356937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable microspheres targeting mucosal immune-regulating cells: new approach for treatment of inflammatory bowel disease.
    Nakase H; Okazaki K; Tabata Y; Chiba T
    J Gastroenterol; 2003 Mar; 38 Suppl 15():59-62. PubMed ID: 12698874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice.
    Sugimoto K; Hanai H; Tozawa K; Aoshi T; Uchijima M; Nagata T; Koide Y
    Gastroenterology; 2002 Dec; 123(6):1912-22. PubMed ID: 12454848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats.
    Sánchez-Hidalgo M; Martín AR; Villegas I; de la Lastra CA
    Eur J Pharmacol; 2007 May; 562(3):247-58. PubMed ID: 17343846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an oral drug delivery system targeting immune-regulating cells in experimental inflammatory bowel disease: a new therapeutic strategy.
    Nakase H; Okazaki K; Tabata Y; Uose S; Ohana M; Uchida K; Matsushima Y; Kawanami C; Oshima C; Ikada Y; Chiba T
    J Pharmacol Exp Ther; 2000 Jan; 292(1):15-21. PubMed ID: 10604927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changtai granule, a traditional Chinese drug, protects hapten-induced colitis by attenuating inflammatory and immune dysfunctions.
    Liu BG; Jia XM; Cao YY; Chen SH; Gao PH; Wang Y; Jiang YY; Cao YB
    J Ethnopharmacol; 2008 Jan; 115(1):1-8. PubMed ID: 17964746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin improves TNBS-induced colitis in rats by inhibiting IL-27 expression via the TLR4/NF-κB signaling pathway.
    Zeng Z; Zhan L; Liao H; Chen L; Lv X
    Planta Med; 2013 Jan; 79(2):102-9. PubMed ID: 23250811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin inhibits trinitrobenzene sulphonic acid-induced colitis in rats by activation of peroxisome proliferator-activated receptor gamma.
    Zhang M; Deng C; Zheng J; Xia J; Sheng D
    Int Immunopharmacol; 2006 Aug; 6(8):1233-42. PubMed ID: 16782535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of the cholinergic anti-inflammatory pathway on experimental colitis.
    Bai A; Guo Y; Lu N
    Scand J Immunol; 2007 Nov; 66(5):538-45. PubMed ID: 17953529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a novel water-soluble vitamin E derivative as a cure for TNBS-induced colitis in rats.
    Isozaki Y; Yoshida N; Kuroda M; Takagi T; Handa O; Kokura S; Ichikawa H; Naito Y; Okanoue T; Yoshikawa T
    Int J Mol Med; 2006 Mar; 17(3):497-502. PubMed ID: 16465398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid-induced colitis.
    Ukil A; Maity S; Karmakar S; Datta N; Vedasiromoni JR; Das PK
    Br J Pharmacol; 2003 May; 139(2):209-18. PubMed ID: 12770926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory intestinal activity of Abarema cochliacarpos (Gomes) Barneby & Grimes in TNBS colitis model.
    da Silva MS; Sánchez-Fidalgo S; Talero E; Cárdeno A; da Silva MA; Villegas W; Souza Brito AR; de La Lastra CA
    J Ethnopharmacol; 2010 Mar; 128(2):467-75. PubMed ID: 20083187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic treatment with ampicillin accelerates the healing of colonic damage impaired by aspirin and coxib in the experimental colitis. Importance of intestinal bacteria, colonic microcirculation and proinflammatory cytokines.
    Zwolinska-Wcislo M; Krzysiek-Maczka G; Ptak-Belowska A; Karczewska E; Pajdo R; Sliwowski Z; Urbanczyk K; Drozdowicz D; Konturek SJ; Pawlik WW; Brzozowski T
    J Physiol Pharmacol; 2011 Jun; 62(3):357-68. PubMed ID: 21893697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Modulation of intestinal mucosal inflammatory factors by curcumin in rats with colitis].
    Jian YT; Wang JD; Mai GF; Zhang YL; Lai ZS
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Dec; 24(12):1353-8. PubMed ID: 15604057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The correlation between NF-κB inhibition and disease activity by coadministration of silibinin and ursodeoxycholic acid in experimental colitis.
    Esmaily H; Vaziri-Bami A; Miroliaee AE; Baeeri M; Abdollahi M
    Fundam Clin Pharmacol; 2011 Dec; 25(6):723-33. PubMed ID: 21077947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vanillin improves and prevents trinitrobenzene sulfonic acid-induced colitis in mice.
    Wu SL; Chen JC; Li CC; Lo HY; Ho TY; Hsiang CY
    J Pharmacol Exp Ther; 2009 Aug; 330(2):370-6. PubMed ID: 19423842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in rats.
    Sánchez-Hidalgo M; Martín AR; Villegas I; Alarcón De La Lastra C
    Biochem Pharmacol; 2005 Jun; 69(12):1733-44. PubMed ID: 15876425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tryptase treatment using nafamostat mesilate has a therapeutic effect on experimental colitis.
    Isozaki Y; Yoshida N; Kuroda M; Handa O; Takagi T; Kokura S; Ichikawa H; Naito Y; Okanoue T; Yoshikawa T
    Scand J Gastroenterol; 2006 Aug; 41(8):944-53. PubMed ID: 16803693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superoxide dismutase ameliorates TNBS-induced colitis by reducing oxidative stress, adhesion molecule expression, and leukocyte recruitment into the inflamed intestine.
    Seguí J; Gironella M; Sans M; Granell S; Gil F; Gimeno M; Coronel P; Piqué JM; Panés J
    J Leukoc Biol; 2004 Sep; 76(3):537-44. PubMed ID: 15197232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,3-Diphenylpropenone ameliorates TNBS-induced rat colitis through suppression of NF-κB activation and IL-8 induction.
    Park SY; Ku SK; Lee ES; Kim JA
    Chem Biol Interact; 2012 Mar; 196(1-2):39-49. PubMed ID: 22410118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.